<div>
 <h2>
  Headline
 </h2>
 <h3>
  Girls just want to have …
  <span class="caps">
   IFNE
  </span>
 </h3>
 <p>
  <a href="https://en.wikipedia.org/wiki/Interferon">
   Interferons
  </a>
  (IFNs) are proteins made and released in answer to the presence of pathogens, such as viruses or bacteria, that trigger the protective defenses of the immune system. In other words, they “interfere” with infections, hence their name. Within the large
  <span class="caps">
   IFN
  </span>
  family, type I IFNs are clustered on a defined locus on
  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15233997">
   chromosome 9p21 in humans and in a region of conserved synteny on chromosome 4 in mice
  </a>
  . Their expression is induced by the activation of signaling pathways downstream of pattern-recognition receptors and they all bind to the
  <span class="caps">
   IFN
  </span>
  -alpha cell surface receptor complex consisting of
  <a href="http://www.uniprot.org/uniprot/?query=gene:IFNAR1+AND+reviewed:yes">
   <span class="caps">
    IFNAR1
   </span>
  </a>
  and
  <a href="http://www.uniprot.org/uniprot/?query=gene:IFNAR2+AND+reviewed:yes">
   <span class="caps">
    IFNAR2
   </span>
  </a>
  chains, leading to the expression of a whole set of genes.
 </p>
 <p>
  There is, however, an alien on the type
  <span class="caps">
   I IFN
  </span>
  locus:
  <span class="caps">
   IFN
  </span>
  -epsilon (IFNE).
  <span class="caps">
   IFNE
  </span>
  shares less than 40% amino acid identity with bona fide type I IFNs, such as
  <span class="caps">
   IFN
  </span>
  -alpha or
  <span class="caps">
   IFN
  </span>
  -beta, but it does still bind to
  <span class="caps">
   IFNAR
  </span>
  , as expected for a type
  <span class="caps">
   I IFN
  </span>
  . However, unlike any of the other family members,
  <a href="http://www.ncbi.nlm.nih.gov/pubmed/23449591">
   it is not induced by the activation of any known pattern-recognition, including Toll-like receptor pathways
  </a>
  . In addition, while other type I IFNs are mainly produced by haemopoietic cells,
  <span class="caps">
   IFNE
  </span>
  is constitutively expressed by epithelial cells of the female reproductive tract in humans and mice. At first glance, these observations seem to challenge a potential protective function for
  <span class="caps">
   IFNE
  </span>
  .
 </p>
 <p>
  In a
  <a href="http://www.ncbi.nlm.nih.gov/pubmed/23449591">
   recent publication
  </a>
  , Fung et al. reported that
  <span class="caps">
   IFNE
  </span>
  expression varied approximately 30-fold at different stages of the estrous cycle in the mouse uterus, with the highest levels at estrus (when estrogen levels are high) and was reduced during pregnancy (when progesterone levels are high). Similarly, in the human endometrium,
  <span class="caps">
   IFNE
  </span>
  levels were highest in the proliferative phase of the menstrual cycle and lowest in postmenopausal women (when estrogen levels are low). The suspected hormonal regulation could then be confirmed in mice and in humans:
  <span class="caps">
   IFNE
  </span>
  is induced by estrogens and reduced by progesterone. What about
  <span class="caps">
   IFNE
  </span>
  function? Fung et al. demonstrated that
  <span class="caps">
   IFNE
  </span>
  regulates
  <span class="caps">
   IFN
  </span>
  -regulated genes, including
  <span class="caps">
   IRF7
  </span>
  and
  <span class="caps">
   ISG15
  </span>
  , as well as 2’5’oligoadenylate synthetase. What is more,
  <em>
   Ifne-/-
  </em>
  female mice, whose vaginas were infected with
  <em>
   Chlamydia muridarum
  </em>
  or herpes simplex virus 2, had more severe clinical disease than wild-type mice, as well as higher levels of virus or bacteria at defined time points after infection. Hence
  <span class="caps">
   IFNE
  </span>
  seems to play an important – though local – protective role against sexually transmitted infections.
 </p>
 <p>
  These very interesting observations may have pinpointed the cause of susceptibility to infections of the reproductive tract in women on progesterone-containing contraception, i.e. a progesterone-induced decrease in
  <span class="caps">
   IFNE
  </span>
  expression.
 </p>
 <p>
  In UniProtKB/Swiss-Prot,
  <a href="http://www.uniprot.org/uniprot/?query=(gene:IFNE)+AND+reviewed:yes">
   <span class="caps">
    IFNE
   </span>
   entries
  </a>
  have been updated accordingly.
 </p>
 <h2>
  UniProtKB news
 </h2>
 <h3>
  Cross-references to GeneWiki
 </h3>
 <p>
  Cross-references have been added to
  <a href="http://en.wikipedia.org/wiki/Gene_Wiki">
   GeneWiki
  </a>
  , an initiative that aims to create seed articles for every notable human gene.
 </p>
 <p>
  GeneWiki is available at
  <a href="http://en.wikipedia.org/wiki/Gene_Wiki">
   http://en.wikipedia.org/wiki/Gene_Wiki
  </a>
 </p>
 <p>
  The format of the explicit links in the flat file is:
 </p>
 <table>
  <tr>
   <th>
    Resource abbreviation
   </th>
   <td>
    GeneWiki
   </td>
  </tr>
  <tr>
   <th>
    Resource identifier
   </th>
   <td>
    GeneWiki identifier
   </td>
  </tr>
  <tr>
   <th>
    Example
   </th>
   <td>
    <a href="http://www.uniprot.org/uniprot/Q96N67#section_x-ref">
     <span class="caps">
      Q96N67
     </span>
    </a>
    :
    <pre>DR   GeneWiki; Dock7; -.</pre>
   </td>
  </tr>
 </table>
 <p>
  <a href="http://www.uniprot.org/uniprot/?query=database%3Agenewiki&amp;sort=score">
   Show all the entries having a cross-reference to GeneWiki.
  </a>
 </p>
 <h3>
  Change of the cross-reference GlycoSuiteDB to UniCarbKB
 </h3>
 <p>
  GlycoSuiteDB, an annotated and curated relational database of glycan structures, has been integrated into
  <a href="http://www.unicarbkb.org/">
   UniCarbKB
  </a>
  , with a new user interface and added functionalities.
 </p>
 <p>
  We therefore changed the corresponding resource abbreviation from GlycoSuiteDB to UniCarbKB.
 </p>
 <p>
  Example:
  <a href="http://www.uniprot.org/uniprot/P02763#section_x-ref">
   <span class="caps">
    P02763
   </span>
  </a>
  :
 </p>
 Previous flat file format:
 <pre>
DR   GlycoSuiteDB; P02763; -.
</pre>
 New flat file format:
 <pre>
DR   UniCarbKB; P02763; -.
</pre>
 <p>
  UniProtKB/Swiss-Prot is currently linked to this resource from the cross-reference section (DR lines), but we also have some site-specific links from the sequence annotation section (FT
  <span class="caps">
   CARBOHYD
  </span>
  ) of
  <a href="http://www.uniprot.org/uniprot/?query=annotation%3A%28type%3Acarbohyd+CAR_*%29">
   relevant UniProtKB/Swiss-Prot entries
  </a>
  . An increase of the number of cross-linked entries is planned, including more literature based glycan data from UniCarbKB.
 </p>
 <h3>
  Removal of the cross-reference to GermOnline
 </h3>
 <p>
  Cross-references to GermOnline have been removed.
 </p>
 <h3>
  Changes to the
  <a href="http://www.uniprot.org/docs/humdisease">
   controlled vocabulary of human diseases
  </a>
 </h3>
 New diseases:
 <ul>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03763">
    Abruzzo-Erickson syndrome
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03718">
    Advanced sleep phase syndrome, familial, 2
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03723">
    Agammaglobulinemia 7, autosomal recessive
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03749">
    Albinism, oculocutaneous, 5
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03728">
    Anemia, hypochromic microcytic, with iron overload 2
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03724">
    Ataxia-oculomotor apraxia 3
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03753">
    Bleeding disorder, platelet-type 15
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03752">
    Bleeding disorder, platelet-type 16
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03742">
    Blepharophimosis-ptosis-intellectual disability syndrome
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03760">
    Bruck syndrome 1
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03761">
    <span class="caps">
     CARD11
    </span>
    immunodeficiency
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03750">
    Cardiomyopathy, dilated 1II
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03729">
    Cardiomyopathy, dilated 1JJ
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03730">
    Cardiomyopathy, dilated 1KK
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03731">
    Cardiomyopathy, familial hypertrophic 22
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03732">
    Cardiomyopathy, familial restrictive 4
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03759">
    Charcot-Marie-Tooth disease, dominant, intermediate type, F
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03710">
    Combined D-2- and L-2-hydroxyglutaric aciduria
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03722">
    Congenital disorder of glycosylation, X-linked
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03743">
    Congenital short bowel and malrotation syndrome
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03734">
    Congenital short bowel syndrome
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03762">
    Corneal intraepithelial dyskeratosis and ectodermal dysplasia
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03755">
    Dyskeratosis congenita, autosomal recessive, 5
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03725">
    Hydrocephalus, non-syndromic, autosomal recessive 2
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03720">
    Hyperphosphatasia with mental retardation syndrome 3
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03764">
    <span class="caps">
     IL21R
    </span>
    immunodeficiency
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03733">
    Intestinal atresia, multiple
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03711">
    Kenny-Caffey syndrome 2
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03735">
    Leukemia, chronic myeloid
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03748">
    Lipodystrophy, familial partial, 5
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03744">
    Lissencephaly 5
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03756">
    Maple syrup urine disease, mild variant
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03738">
    Mitochondrial complex
    <span class="caps">
     III
    </span>
    deficiency, nuclear 2
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03736">
    Mitochondrial complex
    <span class="caps">
     III
    </span>
    deficiency, nuclear 3
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03737">
    Mitochondrial complex
    <span class="caps">
     III
    </span>
    deficiency, nuclear 4
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03739">
    Mitochondrial complex
    <span class="caps">
     III
    </span>
    deficiency, nuclear 5
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03714">
    Mitochondrial complex V deficiency, mitochondrial 1
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03713">
    Mitochondrial complex V deficiency, mitochondrial 2
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03740">
    Mitochondrial complex V deficiency, nuclear 4
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03747">
    Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies
    <span class="caps">
     A11
    </span>
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03721">
    Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies
    <span class="caps">
     A12
    </span>
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03765">
    Myopathy, tubular aggregate
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03715">
    Myxoid liposarcoma
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03751">
    Nephrotic syndrome 8
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03757">
    Neurodegeneration with brain iron accumulation 5
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03741">
    Ohdo syndrome, X-linked
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03712">
    Osteocraniostenosis
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03754">
    Osteogenesis imperfecta 15
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03717">
    Persistent polyclonal B-cell lymphocytosis
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03746">
    Polydactyly, postaxial A6
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03758">
    Progressive external ophthalmoplegia with mitochondrial
    <span class="caps">
     DNA
    </span>
    deletions, autosomal dominant, 6
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03727">
    Retinitis pigmentosa 66
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03726">
    Schizophrenia 18
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03716">
    Smith-McCort dysplasia 2
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03745">
    Spastic paraplegia 46, autosomal recessive
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03719">
    Temtamy syndrome
   </a>
  </li>
  <li>
   <a href="http://www.uniprot.org/diseases/DI-03766">
    Welander distal myopathy
   </a>
  </li>
 </ul>
 Modified diseases:
 <ul>
  <li>
   Agammaglobulinemia 1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01249">
    Agammaglobulinemia 1, autosomal recessive
   </a>
  </li>
  <li>
   Agammaglobulinemia 2 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02888">
    Agammaglobulinemia 2, autosomal recessive
   </a>
  </li>
  <li>
   Agammaglobulinemia 3 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02873">
    Agammaglobulinemia 3, autosomal recessive
   </a>
  </li>
  <li>
   Agammaglobulinemia 4 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02874">
    Agammaglobulinemia 4, autosomal recessive
   </a>
  </li>
  <li>
   Agammaglobulinemia 5 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02875">
    Agammaglobulinemia 5, autosomal dominant
   </a>
  </li>
  <li>
   Agammaglobulinemia 6 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02889">
    Agammaglobulinemia 6, autosomal recessive
   </a>
  </li>
  <li>
   Albinism oculocutaneous 1A -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02088">
    Albinism, oculocutaneous, 1A
   </a>
  </li>
  <li>
   Albinism oculocutaneous 1B -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02089">
    Albinism, oculocutaneous, 1B
   </a>
  </li>
  <li>
   Albinism oculocutaneous 2 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02085">
    Albinism, oculocutaneous, 2
   </a>
  </li>
  <li>
   Albinism oculocutaneous 3 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02090">
    Albinism, oculocutaneous, 3
   </a>
  </li>
  <li>
   Albinism oculocutaneous 4 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02086">
    Albinism, oculocutaneous, 4
   </a>
  </li>
  <li>
   Cataract autosomal dominant -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01200">
    Cataract 9, multiple types
   </a>
  </li>
  <li>
   Cataract autosomal dominant, multiple types 1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01215">
    Cataract 12, multiple types
   </a>
  </li>
  <li>
   Cataract, congenital, cerulean type, 2 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01392">
    Cataract 3, multiple types
   </a>
  </li>
  <li>
   Cataract, congenital, zonular with sutural opacities -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01423">
    Cataract 10, multiple types
   </a>
  </li>
  <li>
   Cataract Coppock-like -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01425">
    Cataract 2, multiple types
   </a>
  </li>
  <li>
   Cataract, crystalline aculeiform -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01456">
    Cataract 4, multiple types
   </a>
  </li>
  <li>
   Cataract juvenile with microcornea and glucosuria -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01327">
    Cataract, juvenile, with microcornea and glucosuria
   </a>
  </li>
  <li>
   Cataract Marner type -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02507">
    Cataract 5, multiple types
   </a>
  </li>
  <li>
   Cataract, posterior polar, 1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02506">
    Cataract 6, multiple types
   </a>
  </li>
  <li>
   Cataract, posterior polar, 4 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02184">
    Cataract 11, multiple types
   </a>
  </li>
  <li>
   Cataract, zonular pulverulent 1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02470">
    Cataract 1, multiple types
   </a>
  </li>
  <li>
   Cleft palate, X-linked -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02436">
    Cleft palate with or without ankyloglossia, X-linked
   </a>
  </li>
  <li>
   Familial advanced sleep-phase syndrome -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01548">
    Advanced sleep phase syndrome, familial, 1
   </a>
  </li>
  <li>
   Familial partial lipodystrophy 2 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01595">
    Lipodystrophy, familial partial, 2
   </a>
  </li>
  <li>
   Familial partial lipodystrophy 3 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01596">
    Lipodystrophy, familial partial, 3
   </a>
  </li>
  <li>
   Familial partial lipodystrophy 4 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-03072">
    Lipodystrophy, familial partial, 4
   </a>
  </li>
  <li>
   Hydrocephalus, non-syndromic, autosomal recessive -&gt;
   <a href="http://www.uniprot.org/diseases/DI-03639">
    Hydrocephalus, non-syndromic, autosomal recessive 1
   </a>
  </li>
  <li>
   Hyperphosphatasia with mental retardation 1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02921">
    Hyperphosphatasia with mental retardation syndrome 1
   </a>
  </li>
  <li>
   Hyperphosphatasia with mental retardation 2 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-03510">
    Hyperphosphatasia with mental retardation syndrome 2
   </a>
  </li>
  <li>
   Hypochromic microcytic anemia -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01787">
    Anemia, hypochromic microcytic, with iron overload 1
   </a>
  </li>
  <li>
   Joubert syndrome -&gt;
   <a href="http://www.uniprot.org/diseases/DI-03108">
    Joubert syndrome 11
   </a>
  </li>
  <li>
   Mitochondrial complex
   <span class="caps">
    III
   </span>
   deficiency -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01982">
    Mitochondrial complex
    <span class="caps">
     III
    </span>
    deficiency, nuclear 1
   </a>
  </li>
  <li>
   Neuropathy, congenital hypomyelinating -&gt;
   <a href="http://www.uniprot.org/diseases/DI-00358">
    Neuropathy, congenital hypomyelinating or amyelinating
   </a>
  </li>
  <li>
   Polydactyly postaxial A1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02397">
    Polydactyly, postaxial A1
   </a>
  </li>
  <li>
   Polydactyly postaxial B -&gt;
   <a href="http://www.uniprot.org/diseases/DI-03100">
    Polydactyly, postaxial B
   </a>
  </li>
  <li>
   Progressive external ophthalmoplegia with mitochondrial
   <span class="caps">
    DNA
   </span>
   deletions autosomal dominant 1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-00943">
    Progressive external ophthalmoplegia with mitochondrial
    <span class="caps">
     DNA
    </span>
    deletions, autosomal dominant, 1
   </a>
  </li>
  <li>
   Progressive external ophthalmoplegia with mitochondrial
   <span class="caps">
    DNA
   </span>
   deletions autosomal dominant 2 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-00944">
    Progressive external ophthalmoplegia with mitochondrial
    <span class="caps">
     DNA
    </span>
    deletions, autosomal dominant, 2
   </a>
  </li>
  <li>
   Progressive external ophthalmoplegia with mitochondrial
   <span class="caps">
    DNA
   </span>
   deletions autosomal dominant 3 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-00945">
    Progressive external ophthalmoplegia with mitochondrial
    <span class="caps">
     DNA
    </span>
    deletions, autosomal dominant, 3
   </a>
  </li>
  <li>
   Progressive external ophthalmoplegia with mitochondrial
   <span class="caps">
    DNA
   </span>
   deletions autosomal dominant 4 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-00946">
    Progressive external ophthalmoplegia with mitochondrial
    <span class="caps">
     DNA
    </span>
    deletions, autosomal dominant, 4
   </a>
  </li>
  <li>
   Progressive external ophthalmoplegia with mitochondrial
   <span class="caps">
    DNA
   </span>
   deletions autosomal dominant 5 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02544">
    Progressive external ophthalmoplegia with mitochondrial
    <span class="caps">
     DNA
    </span>
    deletions, autosomal dominant, 5
   </a>
  </li>
  <li>
   Wagner syndrome 1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02416">
    Wagner vitreoretinopathy
   </a>
  </li>
  <li>
   Weaver syndrome 1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-01141">
    Weaver syndrome
   </a>
  </li>
  <li>
   X-linked Asperger syndrome 1 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02429">
    Asperger syndrome, X-linked, 1
   </a>
  </li>
  <li>
   X-linked Asperger syndrome 2 -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02430">
    Asperger syndrome, X-linked, 2
   </a>
  </li>
  <li>
   X-linked congenital idiopathic intestinal pseudoobstruction -&gt;
   <a href="http://www.uniprot.org/diseases/DI-02438">
    Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked
   </a>
  </li>
 </ul>
 Deleted diseases:
 <ul>
  <li>
   Cataract, congenital, cerulean type, 3
  </li>
  <li>
   Cataract, congenital, non-nuclear polymorphic, autosomal dominant
  </li>
  <li>
   Cataract, cortical, age-related, 2
  </li>
  <li>
   Cataract-microcornea syndrome
  </li>
  <li>
   Cataract, sutural, with punctate and cerulean opacities
  </li>
  <li>
   Cataract, zonular
  </li>
  <li>
   Hereditary non-polyposis colorectal cancer 3
  </li>
  <li>
   Leukotriene C4 synthase deficiency
  </li>
  <li>
   Neuropathy, congenital amyelinating
  </li>
  <li>
   Pallido-ponto-nigral degeneration
  </li>
  <li>
   Platyspondylic lethal skeletal dysplasia Sand Diego type
  </li>
  <li>
   Thromboxane synthetase deficiency
  </li>
  <li>
   Weaver syndrome 2
  </li>
 </ul>
 <h3>
  Changes to the
  <a href="http://www.uniprot.org/docs/ptmlist">
   controlled vocabulary for PTMs
  </a>
 </h3>
 New terms for the feature key ‘Modified residue’ (‘MOD_RES’ in the flat file):
 <ul>
  <li>
   5-glutamyl N2-arginine
  </li>
  <li>
   5-glutamyl N2-glutamate
  </li>
 </ul>
 <h3>
  Changes in
  <a href="http://www.uniprot.org/docs/?subcell">
   subcellular location controlled vocabulary
  </a>
 </h3>
 <p>
  New subcellular location:
 </p>
 <ul>
  <li>
   <a href="http://www.uniprot.org/locations/SL-0484">
    Microtubule organizing center
   </a>
  </li>
 </ul>
</div>